• 1
    Steffansen B, Nielsen CU, Brodin B, et al. Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption. Eur J Pharm Sci 2004;21: 316.
  • 2
    Stewart BH, Kugler AR, Thompson PR, et al. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 1993;10: 27681.
  • 3
    McLean MJ. Gabapentin. Epilepsia 1995;36(suppl 2):S7386.
  • 4
    Hagg S, Spigset O. Anticonvulsant use during lactation. Drug Saf 2000;22: 42540.
  • 5
    Löscher W, Fassbender CP, Gram L, et al. Determination of GABA and vigabatrin in human plasma by a rapid and simple HPLC method: correlation between clinical response to vigabatrin and increase in plasma GABA. Epilepsy Res 1993;14: 24555.
  • 6
    Forrest G, Sills GJ, Leach JP, et al. Determination of GBP in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1996;681: 4215.
  • 7
    Uchino H, Kanai Y, Kim do K, et al. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol 2002;61: 72937.
  • 8
    Okamoto Y, Sakata M, Ogura K, et al. Expression and regulation of 4F2hc and hLAT1 in human trophoblasts. Am J Physiol Cell Physiol 2002;282: C196204.
  • 9
    Nakamura E, Sato M, Yang H, et al. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 1999;274: 300916.
  • 10
    Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 2003;4: 3107.
  • 11
    Blackburn ST. Renal function in the neonate. J Perinat Neonatal Nur 1994;8: 3747.